{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:18:13Z","timestamp":1787919493860,"version":"build-2784847793"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"DOI":"10.7759\/cureus.115346","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:00:32Z","timestamp":1787918432000},"source":"Crossref","is-referenced-by-count":0,"title":["The Great Pretender: Unmasking Persistent Inflammation as Whipple's Disease"],"prefix":"10.7759","author":[{"given":"Carolina","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues","volume":"18","author":"Whipple GH","year":"1907","unstructured":"Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp. 1907, 18:382.","journal-title":"Bull Johns Hopkins Hosp"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00537-X","article-title":"Tropheryma whipplei infection and Whipple's disease","volume":"16","author":"Marth T","year":"2016","unstructured":"Marth T, Moos V, M\u00fcller C, Biagi F, Schneider T. Tropheryma whipplei infection and Whipple's disease. Lancet Infect Dis. 2016, 16:13-22. 10.1016\/S1473-3099(15)00537-X","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.12.009","article-title":"Whipple's disease: a rare disease that can be spotted by many doctors","volume":"121","author":"Cappellini A","year":"2024","unstructured":"Cappellini A, Minerba P, Maimaris S, Biagi F. Whipple's disease: a rare disease that can be spotted by many doctors. Eur J Intern Med. 2024, 121:25-29. 10.1016\/j.ejim.2023.12.009","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70042-2","article-title":"Whipple's disease: new aspects of pathogenesis and treatment","volume":"8","author":"Schneider T","year":"2008","unstructured":"Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis. 2008, 8:179-190. 10.1016\/S1473-3099(08)70042-2","journal-title":"Lancet Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00128-1","article-title":"Whipple's disease and Tropheryma whipplei infections: from bench to bedside","volume":"22","author":"Boumaza A","year":"2022","unstructured":"Boumaza A, Azzouz EB, Arrindell J, Lepidi H, Mezouar S, Desnues B. Whipple's disease and Tropheryma whipplei infections: from bench to bedside. Lancet Infect Dis. 2022, 22:280-291. 10.1016\/S1473-3099(22)00128-1","journal-title":"Lancet Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00033-16","article-title":"Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections","volume":"30","author":"Dolmans RA","year":"2017","unstructured":"Dolmans RA, Boel CH, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017, 30:529-555. 10.1128\/CMR.00033-16","journal-title":"Clin Microbiol Rev"},{"key":"ref7","article-title":"Whipple\u2019s disease","volume":"17","author":"Oliveira L","year":"2010","unstructured":"Oliveira L, Gorj\u00e3o R, Deus JR. Whipple\u2019s disease. J Port Gastrenterol. 2010, 17:69-77.","journal-title":"J Port Gastrenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00797-7","article-title":"Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole in Germany: a phase 2\/3, prospective, open-label, randomised, controlled, non-inferiority trial","volume":"25","author":"Moos V","year":"2025","unstructured":"Moos V, Kr\u00fcger J, Allers K, et al.. Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus intravenous therapy with ceftriaxone followed by oral trimethoprim-sulfamethoxazole in Germany: a phase 2\/3, prospective, open-label, randomised, controlled, non-inferiority trial. Lancet Infect Dis. 2025, 25:788-800. 10.1016\/S1473-3099(24)00797-7","journal-title":"Lancet Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522407-the-great-pretender-unmasking-persistent-inflammation-as-whipples-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:00:32Z","timestamp":1787918432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522407-the-great-pretender-unmasking-persistent-inflammation-as-whipples-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.115346","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}